334 related articles for article (PubMed ID: 32775374)
1. Identification of
Zheng R; Zhu HL; Hu BR; Ruan XJ; Cai HJ
World J Clin Cases; 2020 Jul; 8(14):2917-2929. PubMed ID: 32775374
[TBL] [Abstract][Full Text] [Related]
2. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis.
Zhang XD; Liu ZY; Luo K; Wang XK; Wang MS; Huang S; Li RF
Sci Rep; 2023 Oct; 13(1):16859. PubMed ID: 37803063
[TBL] [Abstract][Full Text] [Related]
4. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
5. Roles of cuproptosis-related gene DLAT in various cancers: a bioinformatic analysis and preliminary verification on pro-survival autophagy.
Yang Q; Zeng S; Liu W
PeerJ; 2023; 11():e15019. PubMed ID: 36949759
[TBL] [Abstract][Full Text] [Related]
6. Pan-cancer analysis from multi-omics data reveals AAMP as an unfavourable prognostic marker.
Wang Y; Liu T; Zhang K; Huang RH; Jiang L
Eur J Med Res; 2023 Jul; 28(1):258. PubMed ID: 37501187
[TBL] [Abstract][Full Text] [Related]
7. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive pan-cancer analysis of the expression characteristics, prognostic value, and immune characteristics of
Fei L; Lu Z; Xu Y; Hou G
Front Genet; 2022; 13():920897. PubMed ID: 36035140
[No Abstract] [Full Text] [Related]
9. Comprehensive analysis of the correlation of the pan-cancer gene HAUS5 with prognosis and immune infiltration in liver cancer.
Zhang W; Yang C; Hu Y; Yi K; Xiao W; Xu X; Chen Z
Sci Rep; 2023 Feb; 13(1):2409. PubMed ID: 36765148
[TBL] [Abstract][Full Text] [Related]
10. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
[TBL] [Abstract][Full Text] [Related]
11. Systematic Analyses of the Role of the Reader Protein of
Shao XY; Dong J; Zhang H; Wu YS; Zheng L
Front Mol Biosci; 2020; 7():577460. PubMed ID: 33344502
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma.
Fan X; Wen J; Bao L; Gao F; Li Y; He D
Front Genet; 2021; 12():681809. PubMed ID: 35095994
[TBL] [Abstract][Full Text] [Related]
13. LINC00638/hsa-miR-29b-3p axis-mediated high expression of CDCA4 correlates with tumor immune infiltration and hepatocellular carcinoma progression.
Wang B; Chen L; Li Q; Zhou J; Jin W
Transl Cancer Res; 2023 May; 12(5):1290-1306. PubMed ID: 37304553
[TBL] [Abstract][Full Text] [Related]
14. Pan-Cancer Analysis Revealed
Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J
J Oncol; 2022; 2022():3477148. PubMed ID: 35069733
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis.
Han X; Long W; Liu Y; Xu J
Front Surg; 2022; 9():985034. PubMed ID: 36338652
[TBL] [Abstract][Full Text] [Related]
16. A novel prognostic biomarker:
Lai T; Peng T; Li J; Jiang Y; Liu K; Yu W; Yao N; Hu Y; Cao M; Liang J
Transl Cancer Res; 2023 May; 12(5):1145-1164. PubMed ID: 37304536
[TBL] [Abstract][Full Text] [Related]
17. Pan-cancer analysis identifies ESM1 as a novel oncogene for esophageal cancer.
Cui Y; Guo W; Li Y; Shi J; Ma S; Guan F
Esophagus; 2021 Apr; 18(2):326-338. PubMed ID: 33175267
[TBL] [Abstract][Full Text] [Related]
18. The prognostic and antitumor roles of key genes of ferroptosis in liver hepatocellular cancer and stomach adenocarcinoma.
Pei W; Jiang M; Liu H; Song J; Hu J
Cancer Biomark; 2024; 39(4):335-347. PubMed ID: 38393890
[TBL] [Abstract][Full Text] [Related]
19. A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors.
Li Y; Fu W; Geng Z; Song Y; Yang X; He T; Wu J; Wang B
PeerJ; 2022; 10():e14432. PubMed ID: 36518297
[TBL] [Abstract][Full Text] [Related]
20. SPARC Overexpression Promotes Liver Cancer Cell Proliferation and Tumor Growth.
Gao ZW; Liu C; Yang L; He T; Wu XN; Zhang HZ; Dong K
Front Mol Biosci; 2021; 8():775743. PubMed ID: 34912848
[No Abstract] [Full Text] [Related]
[Next] [New Search]